Teladoc Health, Inc.
Close on Oct 19, 2026
- Market cap
- $1.04B
- P/E (TTM)
- –
- Dividend yield
- –
About Teladoc Health
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
Teladoc Health provides virtual healthcare services that connect patients with medical professionals for remote clinical care. The company operates through two main segments: Integrated Care and BetterHelp. Its Integrated Care segment offers primary care, urgent care, chronic disease management, mental health services, and medical second opinions, alongside telehealth software and connected devices for health systems. Its BetterHelp segment provides online therapy, counseling, and sleep wellness applications. The company serves individual consumers as well as institutional clients, including employers, health plans, hospital networks, and financial institutions.
The organization maintains operations across five continents and utilizes a network of more than 40,000 healthcare providers, including nearly 35,000 licensed clinicians within its mental health platform. In the United States, approximately 102 million individuals have access to its services. The company's international operations are headquartered in Barcelona, Spain, supported by satellite locations in Canada, Europe, South America, Australia, and Asia.
Summary of the business section of Teladoc Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Teladoc Health, Inc.
- Founded
- 2002
- Headquarters
- New York, NY
- Address
- 155 E 44th Street, Suite 1700 10017
- Phone
- (203) 635-2002
- Website
- www.teladoc.com
- Employees
- 5,600, Dec 31, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, New York, New York
Stock & identifiers
- Ticker
- TDOC
- Exchange
- NYSE
- IPO date
- Jan 19, 2017
- Shares outstanding
- 182M, Jul 23, 2026
- Public float
- $1.53B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1477449
- CUSIP
- 87918A105
- ISIN
- US87918A1051
- LEI
- 549300I2PVFBC9MFAC61
- EIN
- 04-3705970
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Charles Divita Iii | CHIEF EXECUTIVE OFFICER, Director | 465,535 |
| Kelly Bliss | President, U.S. Group Health | 92,832 |
| Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | 117,616 |
| Carlos Nueno | President, International | 64,744 |
| Joseph Ronald Catapano | Chief Accounting Officer | 12,865 |
| Fernando M. Rodrigues | President of BetterHelp | 0 |
| Michael F. Grasher | Chief Financial Officer | – |
| Mala Murthy | CHIEF FINANCIAL OFFICER | 142,385 |
| Mark V. Anquillare | Director | – |
| Mark Douglas Smith | Director | 8,355 |
| David L. Shedlarz | Director | 61,266 |
| David B. Snow Jr | Director | 165,032 |
| Sandra L. Fenwick | Director | 40,702 |
| Kenneth H. Paulus | Director | 10,000 |
| Catherine Jacobson | Director | 66,853 |
| Susan R. Salka | Director | – |
| Michael S. Smith | Director | – |
| Jason Eric Evans | Director | 9,145 |
| Thomas McKinley | Director | 57,098 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Divita | $11.20M | $5.44M | $3.22M | $4 | $148 |
| FY2024 Divita | $16.06M | $5.30M | $3.22M | $5 | $129 |
| FY2024 Gorevic | $9.37M | -$1.25M | $3.22M | $5 | $129 |
| FY2024 Murthy | $5.23M | -$1.09M | $3.22M | $5 | $129 |
| FY2023 Gorevic | $11.61M | $9.40M | $4.94M | $11 | $126 |
| FY2023 Mr. Gorevic | $11.61M | $9.40M | $4.94M | $11 | $126 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed approximately 5,600 people, comprised of approximately 83% full-time employees and 17% part-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 30, 2020 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 3, 2020 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Jul 2, 2020 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 1, 2018 | Name change | Name changed from Teladoc, Inc. to Teladoc Health, Inc. |
| Jun 4, 2018 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 18, 2017 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jan 19, 2017 | IPO | Initial public offering priced (424B4 prospectus) |
| Jul 6, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jun 26, 2015 | Listing | Registration of securities on an exchange (Form 8-A) |